迈威生物-U
(688062)
| 流通市值：51.32亿 | | | 总市值：99.58亿 |
| 流通股本：2.30亿 | | | 总股本：4.47亿 |
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 每股收益(元) | -1.26 | -0.61 | -2.43 | -1.50 | -1.38 | -0.73 | -2.61 | -1.74 |
| 每股净资产(元) | 1.96 | 0.27 | 0.87 | 1.90 | 2.05 | 3.20 | 3.93 | 4.80 |
| 每股资本公积金(元) | 15.13 | 14.41 | 14.41 | 14.41 | 14.41 | 14.91 | 14.91 | 14.91 |
| 每股未分配利润(元) | -14.07 | -15.03 | -14.43 | -13.50 | -13.38 | -12.73 | -12.00 | -11.12 |
| 每股经营性现金流(元) | -1.14 | -0.59 | -0.73 | -0.26 | -0.08 | -0.54 | -2.39 | -1.67 |
| 净资产收益率(%) | -119.41 | -106.04 | -98.93 | -49.68 | -42.63 | -20.50 | -50.28 | -30.84 |
| 营业总收入(元) | 3.13亿 | 1.28亿 | 6.63亿 | 5.66亿 | 1.01亿 | 4478.85万 | 2.00亿 | 1.41亿 |
营业总收入同比增长(%) | 209.04 | 184.89 | 231.62 | 301.03 | -12.43 | -33.70 | 56.28 | 41.79 | | 归属净利润(元) | -52170.77万 | -24194.36万 | -96933.37万 | -59766.01万 | -55131.91万 | -29172.81万 | -104391.92万 | -69409.03万 |
| 归属净利润同比增长(%) | 5.37 | 17.07 | 7.14 | 13.89 | -23.90 | -41.85 | 0.90 | -3.09 |
| 扣非净利润(元) | -51826.35万 | -24180.62万 | -99885.53万 | -62235.54万 | -57353.90万 | -29342.40万 | -106960.54万 | -71463.96万 |
|
| 扣非净利润同比增长(%) | 9.64 | 17.59 | 6.61 | 12.91 | -24.48 | -34.69 | -0.91 | -5.45 |
| 毛利率(%) | 75.46 | 76.15 | 90.27 | 93.15 | 78.70 | 77.73 | 85.51 | 92.46 |
| 净利率(%) | -167.67 | -190.48 | -146.75 | -105.97 | -545.87 | -652.98 | -523.85 | -493.29 |
| 资产负债率(%) | 80.09 | 93.67 | 88.30 | 79.11 | 77.54 | 69.86 | 63.61 | 57.64 |
| 存货周转率(次) | 0.40 | 0.16 | 0.32 | 0.19 | 0.10 | 0.05 | 0.16 | 0.06 |